Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.31
Nov 13 • 3:59 PM ET Dollar change+0.06 Percentage change(4.80%)
Aftermarket Close
1.38
Aftermarket • 7:45 PM ET Dollar change+0.07 Percentage change(5.24%)
Index
-
Market Cap
190.29M
Enterprise Value
207.71M
Income
-157.25M
Sales
227.31M
Book/sh
1.36
Cash/sh
1.31
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
686
IPO
Sep 15, 2021
P/E
-
Forward P/E
6.74
PEG
-
P/S
0.84
P/B
0.96
P/C
1.00
P/FCF
7.87
EV/EBITDA
6.39
EV/Sales
0.91
Quick Ratio
1.87
Current Ratio
1.87
Debt/Eq
1.13
LT Debt/Eq
1.05
Option/Short
Yes / Yes
EPS (ttm)
-1.50
EPS next Y
0.19
EPS next Q
0.04
EPS this Y
-15.07%
EPS next Y
-4.66%
EPS next 5Y
-5.12%
EPS past 3/5Y
-163.26% -19.83%
Sales past 3/5Y
2.75% 15.34%
EPS Y/Y TTM
10.48%
Sales Y/Y TTM
-6.18%
EPS Q/Q
74.48%
Sales Q/Q
-8.99%
Insider Own
70.56%
Insider Trans
0.00%
Inst Own
17.87%
Inst Trans
-6.36%
ROA
-25.28%
ROE
-73.11%
ROIC
-52.72%
Gross Margin
60.03%
Oper. Margin
-9.25%
Profit Margin
-69.18%
SMA20
13.59%
SMA50
25.11%
SMA200
28.65%
Trades
Shs Outstand
106.92M
Shs Float
31.55M
52W High
3.00 -56.33%
52W Low
0.61 114.65%
Volatility
6.98% 7.36%
ATR (14)
0.07
RSI (14)
68.48
Beta
1.35
Rel Volume
0.77
Avg Volume
654.81K
Volume
504,746
Perf Week
13.91%
Perf Month
31.51%
Perf Quarter
104.88%
Perf Half Y
62.15%
Perf YTD
-54.36%
Perf Year
-51.84%
Perf 3Y
-82.58%
Perf 5Y
-96.87%
Perf 10Y
-
Prev Close
1.25
Price
1.31
Change %
4.80%
Consensus
Hold
Avg. Price Target
$1.83
Implied Upside
+39.7%
Analysts14incl. previous ratings
Rating Distribution3 Buy · 8 Hold · 3 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 29, 2026Downgrade
BAC logoBBofA Securities
Buy → Underperform$0.70-46.6%
May 09, 2025Downgrade
BBTIG Research
Buy → Neutral
Jan 13, 2025Downgrade
BCS logoBBarclays
Equal Weight → Underweight$4+205.3%
Dec 20, 2024Initiated
SStephens
Equal-Weight$5+281.7%
Sep 17, 2024Initiated
BBTIG Research
Buy$7+434.4%
Jul 31, 2024Downgrade
JPM logoJJP Morgan
Neutral → Underweight$7 → $5+281.7%
May 08, 2024Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight$11.50 → $9+587.0%
Jan 17, 2024Downgrade
NNeedham
Buy → Hold
Jan 05, 2024Downgrade
CCanaccord Genuity
Buy → Hold
Jul 24, 2023Downgrade
RRobert W. Baird
Outperform → Neutral$13+892.4%
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.
Founder & Executive ChairmanMr. Jason Ronald Krantz
Chief Financial OfficerMs. Casey Heller
CEO & DirectorMr. Clay Ritchey
Chief Legal Officer & SecretaryMr. Jonathan Paris J.D.
SVP & Head of SalesMs. Marissa Peoples Odell